Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Difluprednate in severe anterior uveitis
NCT00407056Phase 3Completed
- Sponsor
- Sirion Therapeutics, Inc.
- Start
- Aug 2002
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, open-label, single-arm trial of difluprednate in anterior uveitis (AU) and panuveitis, sponsored by Sirion Therapeutics, Inc. Primary endpoint: Anterior Chamber Cell Score at Day 14. Started Aug 2002; status: completed.
02
Drugs
difluprednate
03
Conditions
anterior uveitis (AU)panuveitis
Beyond the preview
Go deeper on NCT00407056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00407056.